These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32014680)

  • 1. Structural features and functional activities of benzimidazoles as NOD2 antagonists.
    Guzelj S; Gobec M; Urbančič D; Mlinarič-Raščan I; Corsini E; Jakopin Ž
    Eur J Med Chem; 2020 Mar; 190():112089. PubMed ID: 32014680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2.
    Keček Plešec K; Urbančič D; Gobec M; Pekošak A; Tomašič T; Anderluh M; Mlinarič-Raščan I; Jakopin Ž
    Bioorg Med Chem; 2016 Nov; 24(21):5221-5234. PubMed ID: 27601373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of benzofused five-membered sultams, potent dual NOD1/NOD2 antagonists in vitro and in vivo.
    Ma Y; Li X; Pei Y; Ye J; Wei X; Yang J; Si G; Tian J; Dong Y; Liu G
    Eur J Med Chem; 2020 Oct; 204():112575. PubMed ID: 32731185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THP-1 Cells and Pro-inflammatory Cytokine Production: An in Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists.
    Jakopin Ž; Corsini E
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
    Correa RG; Milutinovic S; Reed JC
    Biosci Rep; 2012 Dec; 32(6):597-608. PubMed ID: 22908883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo.
    Wang S; Yang J; Li X; Liu Z; Wu Y; Si G; Tao Y; Zhao N; Hu X; Ma Y; Liu G
    J Med Chem; 2017 Jun; 60(12):5162-5192. PubMed ID: 28541685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptidic quinazolinone derivatives as dual nucleotide-binding oligomerization domain-like receptor 1/2 antagonists for adjuvant cancer chemotherapy.
    Ma Y; Yang J; Wei X; Pei Y; Ye J; Li X; Si G; Tian J; Dong Y; Liu G
    Eur J Med Chem; 2020 Dec; 207():112723. PubMed ID: 32920426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
    Velloso FJ; Campos AR; Sogayar MC; Correa RG
    BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
    Pashenkov MV; Dagil YA; Pinegin BV
    Int Immunopharmacol; 2018 Jan; 54():385-400. PubMed ID: 29207344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists.
    Russo C; Russomanno P; D'Amore VM; Alfano AI; Santoro F; Guzelj S; Gobec M; Amato J; Pagano B; Marinelli L; Carotenuto A; Tron GC; Di Leva FS; Jakopin Ž; Brancaccio D; Giustiniano M
    J Med Chem; 2024 Feb; 67(4):3004-3017. PubMed ID: 38301029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
    Jakopin Ž
    J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1).
    Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M
    Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages.
    Takahashi Y; Isuzugawa K; Murase Y; Imai M; Yamamoto S; Iizuka M; Akira S; Bahr GM; Momotani E; Hori M; Ozaki H; Imakawa K
    J Vet Med Sci; 2006 May; 68(5):471-8. PubMed ID: 16757890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
    Sato T; Shikama Y; Shimauchi H; Endo Y; Takada H
    Innate Immun; 2011 Feb; 17(1):54-9. PubMed ID: 20083500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Nod1 and Nod2 induces innate immune responses of prostate epithelial cells.
    Kang MJ; Heo SK; Song EJ; Kim DJ; Han SY; Han JH; Kim BY; Park JH
    Prostate; 2012 Sep; 72(12):1351-8. PubMed ID: 22228081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.
    Dagil YA; Arbatsky NP; Alkhazova BI; L'vov VL; Mazurov DV; Pashenkov MV
    PLoS One; 2016; 11(8):e0160784. PubMed ID: 27513337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts.
    Hirao K; Yumoto H; Takahashi K; Mukai K; Nakanishi T; Matsuo T
    J Dent Res; 2009 Aug; 88(8):762-7. PubMed ID: 19734466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection.
    Lee JY; Hwang EH; Kim DJ; Oh SM; Lee KB; Shin SJ; Park JH
    Immunobiology; 2016 Jan; 221(1):70-5. PubMed ID: 26255090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.